Top advances of the year: Reappraisal of systemic versus local therapy for hepatocellular carcinoma. Oyenuga M, McGrew T, Hannan LM, Alese OB, et al. Cancer 2025;131:e70162.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Oyenuga M, McGrew T, Hannan LM, Alese OB, et al. Top advances of the year: Reappraisal of systemic versus local therapy for hepatocellular carcinoma. Cancer 2025;131:e70162.
PMID: 41176643